Cargando…

Rifampicin resistance in Mycobacterium tuberculosis in Iran: a two-centre study

Multidrug-resistant tuberculosis remains a challenge. In this study, we investigated the incidence of rifampicin (RIF) resistance in Mycobacterium tuberculosis in a large number of pulmonary specimens. A two-center study in Tehran, the capital of Iran, was performed with 6624 pulmonary samples of pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bahraminia, F., Zangiabadian, M., Nasiri, M.J., Fattahi, M., Goudarzi, M., Ranjbar, R., Imani Fooladi, A.A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313744/ https://www.ncbi.nlm.nih.gov/pubmed/34336229 http://dx.doi.org/10.1016/j.nmni.2021.100909

Ejemplares similares

Rifampicin-resistant tuberculosis in Iran: A systematic review and meta-analysis
por: Bahraminia, Farhad, et al.
Publicado: (2021)

High-resolution melt curve analysis for rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a single-centre study in Iran
por: Arefzadeh, S., et al.
Publicado: (2020)

High genetic diversity among Mycobacterium tuberculosis strains in Tehran, Iran
por: Azimi, Taher, et al.
Publicado: (2018)

Genotyping and drug susceptibility testing of Mycobacterium tuberculosis in Iran: a multi-centre study
por: Mousavi, S.M.J., et al.
Publicado: (2020)

Rapid Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis using TaqMan Allelic Discrimination
por: Darban-Sarokhalil, Davood, et al.
Publicado: (2016)

Genotyping of Mycobacterium tuberculosis Isolates from Hormozgan Province of Iran Based on 15-Locus MIRU-VNTR and Spoligotyping
por: Zamani, Samin, et al.
Publicado: (2016)

High rates of nontuberculous mycobacteria isolation from patients with presumptive tuberculosis in Iran
por: Nasiri, M.J., et al.
Publicado: (2017)

Spoligotyping and drug resistance patterns of Mycobacterium tuberculosis isolates from five provinces of Iran
por: Haeili, Mehri, et al.
Publicado: (2013)

Mycobacterium simiae pulmonary disease in Iran: systematic review and meta-analysis
por: Nasiri, M.J., et al.
Publicado: (2018)

An evaluation study on phenotypical methods and real-time PCR for detection of Mycobacterium tuberculosis in sputa of two health centers in Iran
por: Sadr, Shirin, et al.
Publicado: (2017)

Performance of Wayne assay for detection of pyrazinamide resistance in Mycobacterium tuberculosis: a meta-analysis study
por: Nasiri, M.J., et al.
Publicado: (2021)

Accurate Detection of Rifampicin-Resistant Mycobacterium Tuberculosis Strains
por: Song, Keum-Soo, et al.
Publicado: (2016)

Rifampicin-Mediated Metabolic Changes in Mycobacterium tuberculosis
por: Yelamanchi, Soujanya D., et al.
Publicado: (2022)

Interpreting very low Mycobacterium tuberculosis detected on Xpert Mycobacterium tuberculosis/rifampicin
por: Ajbani, Kanchan, et al.
Publicado: (2019)

Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
por: Khan, Anwar Sheed, et al.
Publicado: (2021)

Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Malawi
por: Chikaonda, Tarsizio, et al.
Publicado: (2017)

Trends in multidrug-resistant tuberculosis in Tehran, Iran: an analysis of published data
por: Nasiri, Mohammad Javad, et al.
Publicado: (2019)

The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance
por: Lake, M. Alexandra, et al.
Publicado: (2023)

New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria
por: Nasiri, Mohammad J., et al.
Publicado: (2017)

In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015)

Efficacy and role of Xpert(®) Mycobacterium tuberculosis/rifampicin assay in urinary tuberculosis
por: Samuel, Benedict Paul, et al.
Publicado: (2018)

Rifampicin-Resistant Mycobacterium tuberculosis Among Patients with Presumptive Tuberculosis in Addis Ababa, Ethiopia
por: Araya, Shambel, et al.
Publicado: (2020)

Cell wall inhibitors increase the accumulation of rifampicin in Mycobacterium tuberculosis
por: McNeil, Matthew B., et al.
Publicado: (2019)

Evaluation of phage assay for rapid phenotypic detection of rifampicin resistance in Mycobacterium tuberculosis
por: Yzquierdo, Sergio Luis, et al.
Publicado: (2006)

Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda
por: Ogwang, Sam, et al.
Publicado: (2009)

Correction: In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015)

Resistance of Mycobacterium tuberculosis strains to Rifampicin: A systematic review and meta-analysis
por: Feyisa, Seifu Gizaw, et al.
Publicado: (2019)

Diagnostic performance of DNA microarray for detecting rifampicin and isoniazid resistance in Mycobacterium tuberculosis
por: Sun, Bingqi, et al.
Publicado: (2021)

Author Correction: Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
por: Khan, Anwar Sheed, et al.
Publicado: (2021)

Evaluation of FLASH – PCR forrapid detection of Mycobacterium tuberculosis from clinical specimens
por: Imani Fooladi, Abbas Ali, et al.
Publicado: (2013)

Prevalence of rifampicin-resistant Mycobacterium tuberculosis among human-immunodeficiency-virus-seropositive patients and their treatment outcomes
por: Vidyaraj, C.K., et al.
Publicado: (2017)

Bedaquiline Resistance and Molecular Characterization of Rifampicin-Resistant Mycobacterium Tuberculosis Isolates in Zhejiang, China
por: Tong, Enyu, et al.
Publicado: (2023)

High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre
por: Seijger, Charlotte, et al.
Publicado: (2019)

Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda
por: Kigozi, Edgar, et al.
Publicado: (2018)

Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
por: Zhang, Zehua, et al.
Publicado: (2014)

Whole Genome Sequencing Results Associated with Minimum Inhibitory Concentrations of 14 Anti-Tuberculosis Drugs among Rifampicin-Resistant Isolates of Mycobacterium Tuberculosis from Iran
por: Kardan-Yamchi, Jalil, et al.
Publicado: (2020)

Transmission and Drug Resistance Genotype of Multidrug-Resistant or Rifampicin-Resistant Mycobacterium tuberculosis in Chongqing, China
por: Zhao, Bing, et al.
Publicado: (2022)

Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia
por: Jaleta, Kefyalew N, et al.
Publicado: (2017)

Rifampicin resistant Mycobacterium tuberculosis and associated factors among presumptive pulmonary tuberculosis patients in Mogadishu, Somalia
por: Ali, Mohamed Muhumed, et al.
Publicado: (2023)

Detection of Rifampicin Resistance in Mycobacterium tuberculosis by Padlock Probes and Magnetic Nanobead-Based Readout
por: Engström, Anna, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ja22j9msm3d001i34do1srbngb